New injection aims to wake muscles after surgery

NCT ID NCT07195604

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a single dose of HRS-2162 injection in 64 healthy volunteers to see if it is safe and how the body processes it. The drug is designed to reverse neuromuscular blockade, a temporary muscle paralysis used during surgery. Researchers will monitor side effects and measure drug levels in the blood.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

HRS-2162 injection

What this could lead to

If successful, this could lead to a new option for quickly reversing muscle paralysis after surgery or in emergency settings.

What could go wrong

This is an early Phase 1 trial in only 64 healthy people, so safety and effectiveness are not yet proven. It may not work as hoped or could have side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REVERSAL OF NEUROMUSCULAR BLOCKADE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sichuan Academy of Medical Sciences &Sichuan Provincial People's Hospital

    RECRUITING

    Chengdu, Sichuan, 610072, China

    Contact